Veterinary Medicines

Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves

Not authorised
  • Lincomycin hydrochloride
  • Spectinomycin sulfate tetrahydrate
Download as PDF

Product identification

Medicine name:
LINSPEC 50/100 mg/ml SOLUCION INYECTABLE PARA PERROS, GATOS, PORCINO Y TERNEROS PRERRUMIANTES
Linspec 50/100 mg/ml Solution for injection for dogs, cats, pigs and pre-ruminant calves
Active substance:
  • Lincomycin hydrochloride
  • Spectinomycin sulfate tetrahydrate
Target species:
  • Cattle
  • Dog
  • Cat
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    54.49
    milligram(s)
    /
    1.00
    millilitre(s)
  • Spectinomycin sulfate tetrahydrate
    151.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        21
        day
    • Dog
    • Cat
    • Pig
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Revoked
Authorised in:
  • Spain
Package description:
  • 250 ml multi-dose translucent polypropylene vial with bromobutyl stopper and aluminium cap with a flip off seal. Vials is placed in an outer container (paper box).
  • 100 ml multi-dose translucent polypropylene vial with bromobutyl stopper and aluminium cap with a flip off seal. Vial is placed in an outer container (paper box).

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cenavisa S.L.
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 2226 ESP
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0238/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."